Recent Press Releases

Follicept™ Hair Growth Gel Set for Launch in 2015 by UF Transdermal Delivery Startup

February 24, 2015 08:30 AM Eastern Standard Time GAINESVILLE, Fla.--()--With the patent expiration of Rogaine® and Propecia®, there is no longer a clear market leader in the...

Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc.

23rd February 2015 16:30 Business Wire India Ferring Pharmaceuticals announced today that it has signed an agreement with CTCBIO Inc. of Seoul, South Korea to acquire rights to a novel oral drug...

WHO calls for worldwide use of "smart" syringes

23 FEBRUARY 2015 | GENEVA - Use of the same syringe or needle to give injections to more than one person is driving the spread of a number of deadly infectious diseases worldwide. Millions of people...

MRIGlobal awarded contract to develop Sample-to-Sequence system for diagnosis of infectious diseases

MRIGlobal today announced that it has been awarded a $14.8 million contract to develop an end-to-end next generation sequencing system for clinical diagnosis of infectious diseases. MRIGlobal's...

Heat Biologics, Inc. and OncoSec Medical Inc. Announce Collaboration to Evaluate Combination of Immunotherapy Platforms

Collaboration to Evaluate Combination of Heat's Proprietary Impact Platform With OncoSec's Proprietary Intratumoral DNA Delivery Technology to Treat Variety of Cancers DURHAM, N.C. and SAN...

Heat Biologics, Inc. and OncoSec Medical Inc. Announce Collaboration to Evaluate Combination of Immunotherapy Platforms

DURHAM, N.C. and SAN DIEGO, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat") (Nasdaq:HTBX), a clinical stage biopharmaceutical company focused on the development of cancer...

Endo Pharmaceuticals and BioDelivery Sciences Announce Acceptance of NDA for BELBUCA™ (buprenorphine HCl) Buccal Film for the Management of Chronic Pain

DUBLIN and RALEIGH, N.C., Feb. 23, 2015 -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (ENDP) (ENL.TO), and BioDelivery Sciences International, Inc. (BDSI) announced today...

NIH-supported clinical trials to evaluate long-acting, injectable antiretroviral drugs to prevent HIV infection

Two new clinical trials are examining the safety and acceptability of antiretroviral medicines administered via injection as a means of protecting against HIV infection. The studies are being funded...

Collegium Pharmaceutical Announces FDA Acceptance for Filing of NDA for XTAMPZA ER(TM) (Oxycodone Extended-Release Capsules), an Abuse-Deterrent Analgesic for Chronic Pain

CANTON, MA / ACCESSWIRE / February 12, 2015 / Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative abuse-deterrent...

Collegium Pharmaceutical Announces FDA Acceptance for Filing of NDA for XTAMPZA ER(TM) (Oxycodone Extended-Release Capsules), an Abuse-Deterrent Analgesic for Chronic Pain

CANTON, MA / ACCESSWIRE / February 12, 2015 / Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative abuse-deterrent...

pSivida Announces U.S. Shipments of ILUVIEN® for DME to Start February 23

WATERTOWN, Mass.--()--pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products for treating eye diseases, today announced that...

FINDINGS COULD IMPROVE TARGETED CHEMOTHERAPY DRUG DELIVERY

February 11, 2015 Kevin Hattori A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous...

ENGAGE Randomized Clinical Trial Evaluating Cerdelga® (eliglustat) for Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association

- Treatment with Genzyme's Cerdelga® (eliglustat) for nine months results in significant improvements in spleen volume, hemoglobin level, liver volume and platelet count compared to placebo -...

Actavis to Divest Pharmatech to TPG

- TPG to Focus Company on Growth and Development of Innovative Products - - Divestiture Allows Actavis to Sharpen Focus on Supporting Existing Global Supply Chain Network - DUBLIN and FORT WORTH,...

Pfizer Announces FDA Acceptance for Review of a New Drug Application for ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride)

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ALO-02 (oxycodone hydrochloride and naltrexone...

Lipid-Based Solutions to Increase Bioavailability Presented at Drug Delivery and Formulation Summit

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Dr. Vincent...

3M™ Scotchpak™ White Backings and Release Liners Bring Greater Visibility for Transdermal and Dermal Drug Delivery Systems

ST. PAUL, MN – February 4, 2015 – 3M Drug Delivery Systems introduces 3M™ Scotchpak™ White Release Liners and White Backing Film. These transdermal components provide high...

Alkermes Announces Positive Topline Results From Phase 1 Study of ALKS 8700 for Treatment of Multiple Sclerosis

–– Novel, Oral Product Candidate Provided Monomethyl Fumarate Exposures Comparable to TECFIDERA®, With Favorable Gastrointestinal Tolerability –– –– Company...

Sebacia Announces Positive Results of Two Independent Clinical Studies in Acne

DULUTH, Ga., Jan. 28, 2015 /PRNewswire/ -- Sebacia, Inc., a company dedicated to delivering breakthrough topical treatments to advance dermatology, has announced the presentation of positive clinical...

New method shrinks metastatic ovarian cancer and reduces chemotherapy dose

New research in The FASEB Journal suggests that part of a naturally occurring protein inhibitor called 3TSR interacts with another protein called CD36, resulting in a reduction of abnormal tumor...